ArticleMolecular cancer therapeutics2018

Wnt/β-Catenin Pathway Activation Mediates Adaptive Resistance to BRAF Inhibition in Colorectal Cancer.

Guangming Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.